Welcome!

News Feed Item

Cystic Fibrosis Therapeutics in Major Developed Markets to 2019 Infrastructure, Devices, Subscriptions and Operator Revenue: Forecast and Research Report Available at MarketResearchReports.Biz

ALBANY, New York, February 18, 2014 /PRNewswire/ --

MarketResearchReports.Biz includes new market research report " Cystic Fibrosis Therapeutics In Major Developed Markets To 2019 - CFTR Modulators Initiate Drive Towards Personalized Treatment And Market Growth" to its large collection of research reports.

http://www.marketresearchreports.biz/analysis-details/cystic-fibrosis-therapeutics-in-major-developed-markets-to-2019-cftr-modulators-initiate-drive-towards-personalized-treatment-and-market-growth

Research Report has released its pharma report "Cystic Fibrosis Therapeutics in Major Developed Markets to 2019 - CFTR Modulators Initiate Drive Towards Personalized Treatmsent and Market Growth." The value of the Cystic Fibrosis (CF) market is expected to increase significantly in value over the forecast period across the leading eight developed nations, from $695.6 million in 2012 to almost $4.5 billion in 2019. This equates to a Compound Annual Growth Rate (CAGR) of 30.4%. Novel treatments with disease-modifying mechanisms of action are the primary factor driving the growth of the value of the market. The positive impact of new market entrants will offset the effects of key patent losses during the forecast period.

Cystic Fibrosis Transmembrane conductance Regulators (CFTR) modulators are the first type of CF therapy to treat the root cause of the disease rather than the symptoms, and as a result, they offer patients improved relief and quality of life. Kalydeco (ivacaftor), which has been marketed since 2012, was the first CFTR modulator to reach the market, and despite only treating a small proportion of the CF population, it had a large impact on the value of the market. This effect will be repeated on a larger scale when lumacaftor and Ataluren (PTC124) enter the market, as these treatments can be used for a much larger proportion of the CF population. Vertex Pharmaceuticals Inc. are the developers of Kalydeco, lumacaftor and other early phase CFTR modulators, and are therefore expected to play a key role in the development of the future CF market.

Inquiry for more information visit: http://www.marketresearchreports.biz/analysis/186871

Scope

  • A disease introduction, which defines the disease, including symptoms, diagnosis and treatment.
  • An analysis of the CF marketed landscape, including a comparison of the efficacy and safety of the most prominent brands, as well as the unmet needs of CF treatment.
  • A detailed analysis of the CF pipeline, detailing, among other parameters, drug distribution by phase, molecule type and mechanism of action. The CF clinical trial landscape is then analyzed, with a particular emphasis on failure rates across different trial phases as well as the trends in clinical trial size and duration. This section also includes profiles and single product forecasts for the most promising pipeline drugs.
  • An epidemiological forecast of the major CF markets. The projected values include total and treated populations.
  • An in-depth forecasting model for the CF market, which considers the current marketed therapies, in addition to the potential entry of new products into the market. The model consists of a projected outcome, with high and low variance results, depending on the potential performance of pipeline therapies.

To Get Download Full Report with TOC: http://www.marketresearchreports.biz/sample/sample/186871

Reasons to Buy

  • Understand the CF pipeline and the clinical needs it is addressing. In particular, the importance and benefits of CFTR modulators are highlighted and compared with symptomatic treatments.
  • Develop their knowledge of key products that may enter the market before 2019. Detailed profiles of these products are provided, with a focus on their clinical trial performance, as well as how they can be incorporated into the CF treatment plan and what competition they face.
  • Assess the risk associated with CF clinical trials compared with both industry and therapy area averages. In addition, in order to understand the trends in both trial size and duration according to mechanism of action or molecule type.

TABLE OF CONTENT

1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 Disease Introduction
2.2 Symptoms
2.3 Etiology
2.4 Pathophysiology
2.5 Diagnosis

3 Marketed Products
3.1 Overview
3.2 Product Profiles
3.2.1 Pulmozyme (dornase alfa) - Genentech
3.2.2 Bronchitol (mannitol) - Pharmaxis
3.2.3 TOBI (tobramycin) - Novartis
3.2.4 TOBI Podhaler (tobramycin) - Novartis
3.2.5 Bramitob/Bethkis (tobramycin) - Chiesi Farmaceutici
3.2.6 Colobreathe (colistimethate sodium) - Forest Laboratories

4 Developmental Pipeline
4.1 Overview
4.2 Mechanisms of Action in the Pipeline
4.3 Clinical Trials
4.3.1 Failure Rate
4.3.2 Clinical Trial Duration
4.3.3 Clinical Trial Size
4.4 Promising Pipeline Molecules
4.4.1 Lumacaftor (VX809) - Vertex Pharmaceuticals

Latest Reports:

Glyphosate Market For Genetically Modified And Conventional Crops - Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2013 - 2019

http://www.marketresearchreports.biz/analysis-details/glyphosate-market-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019

Growing demand from key end-use applications in glyphosate tolerant GM crops and conventional crops is expected to boost the global demand for glyphosate. The agriculture sector is witnessing rapid growth in Asia Pacific, Latin America and other regions, thus fuelling the demand for glyphosate. However, unfavorable factors such as emergence of glyphosate resistant weeds and stringent environmental regulations over use of agrochemicals, especially in Europe, are expected to hinder market growth. Development of innovative integrated weed management systems is expected to catch up in the near future owing to their eco friendly characteristics.

To Get Free Download Full Report With TOC: http://www.marketresearchreports.biz/sample/sample/171893

This report gives a detailed description of the global glyphosate market based on volume share (kilo tons) and revenue (USD million) for the period 2013 to 2019. The report highlights the factors contributing towards the growth of the market and the restraints that impede the market. Detailed forecasts for the years 2013-2019 for glyphosate have been given separately, for better understanding of the market scenario. The glyphosate market is described with respect to their various segments along with the opportunities that are expected in the coming six years.

For geographic analysis, the global glyphosate market has been segmented into regions such as North America, Europe, Asia Pacific, Latin America and Rest of the World (RoW) - The glyphosate market has been segmented based on the following applications - glyphosate resistant GM crops, conventional crops. The study also analyses market attractiveness based on regional segments with the help of the market attractiveness tool.

Contact Lens Market (Gas Permeable Contact Lens and Soft Contact Lens) - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019

http://www.marketresearchreports.biz/analysis-details/contact-lens-market-gas-permeable-contact-lens-and-soft-contact-lens-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019

Contact lens are medical devices that offer convenience, confidence and self-esteem to the people who need vision correction. Factors such as rising ophthalmic disorders, vision problem and changing lifestyle accentuates the uptake of contact lenses during the forecast period. In addition, therapeutic, aesthetic and cosmetic are the major reasons driving the growth of contact lens market globally. The market for contact lens is segmented as by characteristics (gas-permeable and soft contact lens), by design (spherical, toric, soft, multifocal, cosmetic and orthokeratology contact lens) and by usage (corrective, therapeutic, post-operative, cosmetic, enhancement, opaque and special effect, prosthetic, computer, D-segment, sports and custom-made). The report includes market estimations of the global contact lens market in terms of value (USD million) for the period 2013 - 2019, considering 2012 as the base year. In addition, current market trends and recent developments are taken into consideration while determining the growth rate of the global contact lens market. The report provides market size and forecasts for each segment and geographic region with CAGR % for the period from 2013 to 2019.

The market is also forecasted in terms of value (USD million) for the period 2013 - 2019 for four major geographic regions, namely North America, Europe, Asia-Pacific and Rest of the World (RoW). A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the contact lens market and future opportunities are provided in the report. A PESTLE analysis has also been done while estimating individual geographies in order to provide current as well as future status. A list of recommendations for existing as well as new entrants has been discussed in the study which would help in decision making.

To Get Free Download Full Report with TOC: http://www.marketresearchreports.biz/sample/sample/187691

The global Contact Lens market is segmented into the following categories:

Contact Lens Market, by Characteristics

  • Gas-Permeable Contact Lens
  • Soft Contact Lens
  • Daily Disposable
  • Weekly Replacement
  • Monthly Replacement
  • Extended Wear

Contact Lens Market, by Design

  • Spherical Contact Lens
  • Toric Contact Lens
  • Multifocal Contact Lens

Biopreservation Market (Product Types - Equipment, LIMS, And Media; Applications - Regenerative Medicine, Biobanking, And Drug Discovery) - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019

http://www.marketresearchreports.biz/analysis-details/biopreservation-market-product-types-equipment-lims-and-media;-applications-regenerative-medicine-biobanking-and-drug-discovery-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019

This report encompasses market estimations for biopreservation market for the forecast period 2013 to 2019. The market size is forecasted considering 2012 as the base year and is represented in terms of USD million. The report caters to market players in the biopreservation industry who aspire to gain further insights into this market in terms of different product types and application markets.

The global biopreservation market is categorized on the basis of product type, application and geography. The market estimates, from the period 2011 to 2019, for each of these segments is provided in USD million.

To Get Download Full Report With TOC: http://www.marketresearchreports.biz/sample/sample/187694

The biopreservation market, by products is segmented into equipment, laboratory information management systems (LIMS) and media. The market for equipment is further analyzed as freezers, refrigerators, liquid nitrogen tanks and consumables. In addition, the media market is segmented into two types of formulations as home-brew media and pre-formulated media.

The biopreservation market, by applications is segmented into regenerative medicine, biobanking and drug discovery. Geographically, the biopreservation market is estimated and analyzed with respect to four regions namely North America, Europe, Asia-Pacific and Rest of the World.

About us

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-997-4948
E: [email protected]
To Get Latest Reports from Same Publisher: http://www.marketresearchreports.biz/publisher/2

SOURCE MarketResearchReports.Biz

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
The technologies behind big data and cloud computing are converging quickly, offering businesses new capabilities for fast, easy, wide-ranging access to data. However, to capitalize on the cost-efficiencies and time-to-value opportunities of analytics in the cloud, big data and cloud technologies must be integrated and managed properly. Pythian's Director of Big Data and Data Science, Danil Zburivsky will explore: The main technology components and best practices being deployed to take advantage...
For years the world's most security-focused and distributed organizations - banks, military/defense agencies, global enterprises - have sought to adopt cloud technologies that can reduce costs, future-proof against data growth, and improve user productivity. The challenges of cloud transformation for these kinds of secure organizations have centered around data security, migration from legacy systems, and performance. In our presentation, we will discuss the notion that cloud computing, properl...
Chris Matthieu is the President & CEO of Computes, inc. He brings 30 years of experience in development and launches of disruptive technologies to create new market opportunities as well as enhance enterprise product portfolios with emerging technologies. His most recent venture was Octoblu, a cross-protocol Internet of Things (IoT) mesh network platform, acquired by Citrix. Prior to co-founding Octoblu, Chris was founder of Nodester, an open-source Node.JS PaaS which was acquired by AppFog and ...
By 2021, 500 million sensors are set to be deployed worldwide, nearly 40x as many as exist today. In order to scale fast and keep pace with industry growth, the team at Unacast turned to the public cloud to build the world's largest location data platform with optimal scalability, minimal DevOps, and maximum flexibility. Drawing from his experience with the Google Cloud Platform, VP of Engineering Andreas Heim will speak to the architecture of Unacast's platform and developer-focused processes.
The deluge of IoT sensor data collected from connected devices and the powerful AI required to make that data actionable are giving rise to a hybrid ecosystem in which cloud, on-prem and edge processes become interweaved. Attendees will learn how emerging composable infrastructure solutions deliver the adaptive architecture needed to manage this new data reality. Machine learning algorithms can better anticipate data storms and automate resources to support surges, including fully scalable GPU-c...
The vast majority of businesses now use cloud services, yet many still struggle with realizing the full potential of their IT investments. In particular, small and medium-sized businesses (SMBs) lack the internal IT staff and expertise to fully move to and manage workloads in public cloud environments. Speaker Todd Schwartz will help session attendees better navigate the complex cloud market and maximize their technical investments. The SkyKick co-founder and co-CEO will share the biggest challe...
When applications are hosted on servers, they produce immense quantities of logging data. Quality engineers should verify that apps are producing log data that is existent, correct, consumable, and complete. Otherwise, apps in production are not easily monitored, have issues that are difficult to detect, and cannot be corrected quickly. Tom Chavez presents the four steps that quality engineers should include in every test plan for apps that produce log output or other machine data. Learn the ste...
While some developers care passionately about how data centers and clouds are architected, for most, it is only the end result that matters. To the majority of companies, technology exists to solve a business problem, and only delivers value when it is solving that problem. 2017 brings the mainstream adoption of containers for production workloads. In his session at 21st Cloud Expo, Ben McCormack, VP of Operations at Evernote, discussed how data centers of the future will be managed, how the p...
With more than 30 Kubernetes solutions in the marketplace, it's tempting to think Kubernetes and the vendor ecosystem has solved the problem of operationalizing containers at scale or of automatically managing the elasticity of the underlying infrastructure that these solutions need to be truly scalable. Far from it. There are at least six major pain points that companies experience when they try to deploy and run Kubernetes in their complex environments. In this presentation, the speaker will d...
Predicting the future has never been more challenging - not because of the lack of data but because of the flood of ungoverned and risk laden information. Microsoft states that 2.5 exabytes of data are created every day. Expectations and reliance on data are being pushed to the limits, as demands around hybrid options continue to grow.
Enterprises are striving to become digital businesses for differentiated innovation and customer-centricity. Traditionally, they focused on digitizing processes and paper workflow. To be a disruptor and compete against new players, they need to gain insight into business data and innovate at scale. Cloud and cognitive technologies can help them leverage hidden data in SAP/ERP systems to fuel their businesses to accelerate digital transformation success.
Machine learning provides predictive models which a business can apply in countless ways to better understand its customers and operations. Since machine learning was first developed with flat, tabular data in mind, it is still not widely understood: when does it make sense to use graph databases and machine learning in combination? This talk tackles the question from two ends: classifying predictive analytics methods and assessing graph database attributes. It also examines the ongoing lifecycl...
Wooed by the promise of faster innovation, lower TCO, and greater agility, businesses of every shape and size have embraced the cloud at every layer of the IT stack – from apps to file sharing to infrastructure. The typical organization currently uses more than a dozen sanctioned cloud apps and will shift more than half of all workloads to the cloud by 2018. Such cloud investments have delivered measurable benefits. But they’ve also resulted in some unintended side-effects: complexity and risk. ...
Everyone wants the rainbow - reduced IT costs, scalability, continuity, flexibility, manageability, and innovation. But in order to get to that collaboration rainbow, you need the cloud! In this presentation, we'll cover three areas: First - the rainbow of benefits from cloud collaboration. There are many different reasons why more and more companies and institutions are moving to the cloud. Benefits include: cost savings (reducing on-prem infrastructure, reducing data center foot print, r...
Daniel Jones is CTO of EngineerBetter, helping enterprises deliver value faster. Previously he was an IT consultant, indie video games developer, head of web development in the finance sector, and an award-winning martial artist. Continuous Delivery makes it possible to exploit findings of cognitive psychology and neuroscience to increase the productivity and happiness of our teams.